BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34971399)

  • 1. Poor Adherence to Oral Psychiatric Medication in Adults with Bipolar Disorder: The Psychiatrist May have More Influence than in Other Severe Mental Illnesses.
    De Las Cuevas C; Villasante-Tezanos GA; Motuca M; Baptista T; Lazary J; Pogany L; De Leon J
    Neuropsychopharmacol Hung; 2021 Dec; 23(4):347-362. PubMed ID: 34971399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor Adherence to Oral Psychiatric Medication in Adults with Schizophrenia May Be Influenced by Pharmacophobia, High Internal Health Locus of Control and Treatment Duration.
    De Las Cuevas C; Baptista T; Motuca M; Villasante-Tezanos GA; Lazary J; Pogany L; De Leon J
    Neuropsychopharmacol Hung; 2021 Dec; 23(4):388-404. PubMed ID: 34971496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor Adherence to Oral Psychiatric Medication in Adults with Depression: Psychological Reactance May Have Specific Effects in Depression.
    De Las Cuevas C; Motuca M; Baptista T; Villasante-Tezanos GA; Lazary J; Pogany L; De Leon J
    Neuropsychopharmacol Hung; 2021 Dec; 23(4):374-387. PubMed ID: 34971495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to psychiatric medications: Comparing patients with schizophrenia, bipolar disorder and major depression.
    Lazary J; Pogany L; De Las Cuevas C; Villasante-Tezanos GA; De Leon J
    Neuropsychopharmacol Hung; 2021 Dec; 23(4):363-373. PubMed ID: 34971494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical Approach to Measuring and Predicting Medication Adherence by Outpatient's SelfReport After More than 10 Years of Research in Psychopharmacology.
    De Las Cuevas C; Lazary J; Poganyi L; De Leon J
    Neuropsychopharmacol Hung; 2021 Dec; 23(4):336-346. PubMed ID: 34971305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skepticism and pharmacophobia toward medication may negatively impact adherence to psychiatric medications: a comparison among outpatient samples recruited in Spain, Argentina, and Venezuela.
    De Las Cuevas C; Motuca M; Baptista T; de Leon J
    Patient Prefer Adherence; 2018; 12():301-310. PubMed ID: 29503532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of impact of pharmacophilia and pharmacophobia on medication adherence in patients with psychiatric disorders: A cross-sectional study.
    Christudas MJ; Gupta BS; Undela K; Isaac NM; Ram D; Ramesh M
    Indian J Pharmacol; 2016; 48(6):701-705. PubMed ID: 28066110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of necessity-concern framework and polypharmacy on treatment adherence in psychiatric patients. Comparing an Argentinian with a Spanish sample.
    De Las Cuevas C; Villasante-Tezanos AG; Motuca M; de Leon J
    Hum Psychopharmacol; 2021 Jul; 36(4):e2776. PubMed ID: 33508164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey.
    Shinozaki M; Yasui-Furukori N; Adachi N; Ueda H; Hongo S; Azekawa T; Kubota Y; Katsumoto E; Edagawa K; Goto E; Miki K; Kato M; Nakagawa A; Kikuchi T; Tsuboi T; Watanabe K; Shimoda K; Yoshimura R
    Asian J Psychiatr; 2022 Jan; 67():102935. PubMed ID: 34844178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder - A nationwide cohort study.
    Lintunen J; Lähteenvuo M; Tanskanen A; Tiihonen J; Taipale H
    J Affect Disord; 2023 Jul; 333():403-408. PubMed ID: 37084972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder.
    Teter CJ; Falone AE; Bakaian AM; Tu C; Ongür D; Weiss RD
    Psychiatry Res; 2011 Dec; 190(2-3):253-8. PubMed ID: 21696830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
    Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
    J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of gender and gender identity to treatment adherence among individuals with bipolar disorder.
    Sajatovic M; Micula-Gondek W; Tatsuoka C; Bialko C
    Gend Med; 2011 Aug; 8(4):261-8. PubMed ID: 21763217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotic adherence is associated with lower inpatient utilization and cost in bipolar I disorder.
    Broder MS; Greene M; Chang E; Hartry A; Yan T; Yermilov I
    J Med Econ; 2019 Jan; 22(1):63-70. PubMed ID: 30376745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication Adherence in Pediatric Patients with Bipolar Disorder: A Systematic Review.
    Sanchez M; Lytle S; Neudecker M; McVoy M
    J Child Adolesc Psychopharmacol; 2021 Mar; 31(2):86-94. PubMed ID: 33465006
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing patterns of antidepressants, antipsychotics and mood stabilizers in bipolar patients misdiagnosed with major depressive disorder in China.
    Xiang YT; Hu C; Wang G; Zheng QW; Fang YR; Ungvari GS; Kilbourne AM; Lai KY; Si TM; Chen DF; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
    Hum Psychopharmacol; 2012 Nov; 27(6):626-31. PubMed ID: 23027671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: results from the FACE-BD cohort.
    Belzeaux R; Correard N; Boyer L; Etain B; Loftus J; Bellivier F; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Henry C; Azorin JM;
    J Affect Disord; 2013 Dec; 151(3):1009-15. PubMed ID: 24051101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders - an 18-month prospective study.
    Arvilommi P; Suominen K; Mantere O; Leppämäki S; Valtonen H; Isometsä E
    J Affect Disord; 2014 Feb; 155():110-7. PubMed ID: 24262639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the Patient's Health Belief Questionnaire on Psychiatric Treatment.
    De Las Cuevas C; de Leon J
    Patient Prefer Adherence; 2019; 13():527-536. PubMed ID: 31040653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explaining pharmacophobia and pharmacophilia in psychiatric patients: relationship with treatment adherence.
    De Las Cuevas C; Peñate W
    Hum Psychopharmacol; 2015 Sep; 30(5):377-83. PubMed ID: 26010762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.